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Summary The aim of this study was to evaluate the tissue infiltration and phenotypic adhesion profile of 5T2 multiple myeloma (MM) and
5T33 MM cells and to correlate it with that observed in human disease. For each line, 30 mice were intravenously inoculated with myeloma
cells and at a clear-cut demonstrable serum paraprotein concentration; mice were sacrificed and a number of organs removed. The
haematoxylin-eosin stainings on paraffin sections were complemented with immunohistochemistry using monoclonal antibodies developed
against the specific MM idiotype. When analysed over time, 5T2 MM cells could be observed in bone marrow samples from week 9 after
transfer of the cells. For the 5T33 MM, a simultaneous infiltration was observed in bone marrow, spleen and liver 2 weeks after inoculation.
Osteolytic lesions consistently developed in the 5T2 MM, but this was not consistent for 5T33 MM. PCNA staining showed a higher
proliferative index forthe 5T33 MM cells. The expression of adhesion molecules was analysed by immunohistochemistry on cytosmears: both
5T2 MM and 5T33 MM cells were LFA-1, CD44, VLA-4 and VLA-5 positive. We conclude that both lines have a phenotypic adhesion profile
analogous to that of human MM cells. As the 5T2 MM cells are less aggressive than the 5T33 MM cells, their organ distribution is more
restricted to the bone marrow and osteolytic lesions are consistently present, the former cell line induces myeloma development similarto the
human disease.
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Multiple myeloma (MM) is a B-cell neoplasm characterized by
clonal expansion ofmalignantplasma cells secreting a monoclonal
immunoglobulin (Ig). The disease is mainly localized in the bone
marrow. In this microenvironment the myeloma plasma cells
receive signals necessary for their proliferation, terminal differen-
tiation and for the secretion of osteoclast-activating factors. The
osteoclast-activating factors recruit osteoclasts, which induce in
situ osteolytic bone lesions (Bataille et al, 1989; Alsina et al,
1996); this is one ofthe major characteristics ofthe disease. It has
been suggested that both cytokines and adhesion molecules are
involved in this complex network of signals (Van Riet and Van
Camp, 1993).
To elucidate the exact mechanisms described above, an in vivo
MM model is necessary. Radl et al (1979) found that 0.5% of
ageing C57BL/KaLwRij mice spontanously developed a disease
reminiscent ofMM. The MM cells isolated from the bone marrow
of different mice (5T MM) did not grow in vitro but could be
transplanted by intravenous injection into young recipients of the
same strain. This transplantable model resembles the human
disease in several aspects (Radl et al, 1988): myeloma occurred
spontaneously, the frequency ofdevelopment ofthe disease is age
related, tumour load can be assessed by paraproteinaemia and the
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concentration ofnormal Ig is depressed in the serum. Several trans-
plantable ST MM cell lines were developed (Radl et al, 1988).
In order to understand the homing mechanisms of the 5T MM
cells to the bone marrow, it was essential to determine accurately
the organs infiltrated by and the adhesion molecules expressed on
these MM cells. We chose the 5T2 and 5T33 MM lines and
analysed their organ distribution after intravenous transfer into
C57BL/KaLwRij mice. The histopathological findings could be
confirmed by immunohistochemistry using monoclonal antibodies
that we developed against the myeloma protein idiotype of each
line. Transmission electron microscopy was further performed to
describe the ultrastructure ofthe cells. The proliferation ofthe MM
cells was estimated by PCNA (proliferating cell nuclear antigen)
staining. Kinetic experiments were performed to elucidate whether
the infiltration occurred simultaneously in the different organs or
whether the bone marrow was infiltrated primarily.
The phenotypic adhesion profile and organ distribution of both
lines was compared so that the best model with the closest resem-
blance to the human disease could be selected for future studies.
MATERIALS AND METHODS
Animals
C57BL/KaLwRijHsd mice were purchased from Harlan CPB
(Zeist, The Netherlands). Male mice were 6-10 weeks old when
used. They were housed under conventional conditions and had
free access to tap water and food. They were killed by cervical
dislocation.
4510.1 X 106 mononuclearcells were injected intravenously (tail vein)
for the 5T2 and 5T33 MM lines respectively.
Quantification of serum paraprotein content
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Figure 1 FACS-staining with anti-idiotype MAb against 5T2 MM (A) and
5T33 MM (B). Bi was used as control antibody (open curve). A clear shift in
fluorescence intensity was observed when anti-idiotype antibodies were used
(filled curve)
Cell lines
The 5T2 and 5T33 MM originated spontaneously in
C57BL/KaLwRij mice (Radl et al, 1979). These lines have since
been transplanted into young syngeneic recipients. For the 5T2
MM generation XIII and for 5T33 MM generation XV (number of
in vivo passages) were used. The development of MM could be
assessed by a specific ELISA or protein electrophoresis of the
serum samples. When serum paraprotein concentrations reached
a level of more than 10 mg ml-l, mice were killed and bone
marrow was flushed from femurs, tibiae and humeri. The isolated
cells were suspended in RPMI-1640 medium (Gibco, Life
Technologies, Gent, Belgium) supplemented with glutamine,
penicillin-streptomycin and MEM (Gibco). After washing twice
with RPMI-1640 medium, mononuclear cells were isolated by
Lympholyte M (Ledarlane, Hornby, Ontario, Canada) gradient
centrifugation at 450 g for 20 min and cell number and viability
were assessed by trypan blue exclusion. Subsequently, 2 x 106 or
The serum paraprotein content could be determined by agar elec-
trophoresis or by ELISA. After electrophoresis in agar (Rapid
Electrophoresis, Helena Laboratories, Baxter, Chicago, IL, USA),
separated proteins were stained with Ponceau S (REP gel
processor, Baxter) followed by scanning densitometry (EDC
densitometer, Baxter) to quantify the relative percentage of each
band. To determine the actual concentration of the paraprotein in
the serum, the relative percentage of the M-spike was subse-
quently combined with the concentration of total protein in the
serum (Ektachem, Johnson&Johnson Clinical Diagnostics,
Rochester, NY, USA).
When ELISA was used to detect the serum paraprotein, anti-
idiotype antibodies were adsorbed at 4°C overnight on 96-well
microtitre plates (Sero-Wel, Sterilin, Staffordshire, UK) at a
concentration of 5 ,ug ml-1 in phosphate-buffered saline (PBS).
Before use, the coated plates were washed with a solution of0.9%
sodium chloride and 0.05% Nonidet P40 (BDH, Poole, UK) and
aspecific binding places were blocked by incubating the plates
with 5% non-fat dry milk in PBS for at least 1 h at room tempera-
ture. After washing, mouse serum collected by tail vein puncture
was added in serial twofold dilutions in PBS-5% non-fat dry milk
to the plates for 1 h. Goat anti-mouse IgG2a-specific antibodies
coupled to horseradish peroxidase (Nordic Immunological
Laboratories, Tilburg, The Netherlands) or goat anti-mouse IgG2b-
specific antibodies coupled to horseradish peroxidase (Southern
Biotechnology Associates, Birmingham, AL) were subsequently
added to detect 5T2 or 5T33 MM monoclonal Ig respectively.
After incubation, the plates were washed and 100 gl of enzyme
substrate 2,2'-azinobis(3-ethylbenzthiazoline-sulphonic acid)
(ABTS, Sigma-Aldrich, Bornem, Belgium) was added. The
absorbance of the coloured reaction product was measured by
an ELISA reader at 414 nm (Titertek Multiscan MC, Flow
Laboratories, McLean, VA, USA). Normal mouse serum was used
as negative control while purified paraprotein diluted in normal
mouse serum was used as standard.
Anti-idiotype monoclonal antibodies
For the development of anti-idiotype antibodies against both 5T2
and 5T33 MM monoclonal Ig, serum of diseased mice was
collected, precipitated twice with ammonium sulphate (45%
saturation) and centrifuged at 1200 g (Sorvall RC SC, Du Pont,
Meyvis, Kapellen, Belgium). The pellet was resuspended, dialysed
against PBS and purified on a protein A column (CNBR Sepharose
4B, Pharmacia, Uppsala, Sweden). The paraprotein was eluted
with 0.1 M citric acid at pH 4.0. After dialysis, 1 mg of purified
paraprotein was coupled to keyhole limpet haemocyanin (KLH)
(Calbiochem, La Jolla, CA, USA). The C57BL/KaLwRijHsd mice
were immunized with the KLH-coupled paraprotein with Freunds
as adjuvant (Life Technologies, Gent, Belgium) (Brissinck et al,
1991). On day 17, isolated spleen cells were fused by polyethylene
glycol (Merck, Belgolabo, Overijse, Belgium) with hypoxanthine
aminopterine thymidine (HAT)-sensitive P3X63-Ag.8.653 cells
(CRL 1580, ATCC, Rockville, MD, USA). The fused cells were
cultured in 96-well flat-bottom plates (Falcon, Beckton Dickinson,
Erembodegem, Belgium) in HAT selection medium (Gibco, Life
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Figure 2 Light micrographs of the invasion in (A) 5T2 MM in bone marrow (Giemsa staining, bar = 0.1 mm), (B) 5T2 MM in spleen (HES staining,
bar = 0.1 mm), (C) 5T33 MM in bone marrow (HES-staining, bar = 0.01 mm), (D) 5T33 MM in spleen (HES staining, bar = 0.01 mm), (E) 5T33 MM in lymph
node (HES staining, bar = 0.01 mm) and (F) 5T33 MM in liver (HES staining, bar = 0.01 mm)
Technologies, Gent, Belgium). Three weeks after fusion,
hybridomas were screened for secretion of antibodies specific for
the 5T2 or 5T33 MM paraprotein. For this purpose, an ELISA
technique was performed following the method described above.
Briefly, the relevant paraprotein was adsorbed on the microtitre
plates at a concentration of 5 gg ml and test supematant (50 gl)
was added to the ELISA plates for 1 h, followed by the incubation
of goat antimouse IgG,, IgM and IgG2a or IgG2b (depending on the
isotype ofthe MM paraprotein) horseradish peroxidase-conjugated
antibodies. Subsequently, 100 ,l ofsubstrate (ABTS) was added to
each well and absorbance was measured with an ELISA reader.
Positive clones were selected, cultured on HT medium and
subcloned twice. Hybridomas were cultured in complete medium
containing 1% serum, then the supematants were harvested. For
both 5T2 and 5T33 MM, two anti-idiotype monoclonal antibodies
(MAbs) of the IgGi isotype were obtained. The antibodies were
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Figure 3 Immunostaining of (A) 5T2 MM cells (bar = 0.01 mm) with anti-idiotype antibodies on cytosmears by the immunogold-silver method and
counterstained with May-Grunwald-Giemsa and (B) 5T33 MM cells (bar = 0.01 mm) with anti-idiotype antibodies on cryostat sections, counterstained with
haematoxylin
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Figure 4 Invasion of 5T2 MM and 5T33 MM, 13 and 4 weeks after inoculation respectively. The invasion of the 5T2 MM in spleen and liver was minor
compared with that by 5T33 MM. Thirty mice were evaluated for both lines (*20- to 30-fold splenomegaly; **1 .5-fold splenomegaly; 'threefold hepatomegaly)
isolated by binding to a protein A column [after adjusting the
culture supernatant to 1 M glycine and 3 M sodium chloride
(pH 8.9) and eluted with 0.1 M citric acid (pH 5.5)].
The binding of these anti-idiotype MAbs to the corresponding
paraproteins could not be inhibited by normal mouse serum in the
ELISA test. Any reaction to other paraproteins ofthe same isotype
in ELISA was absent. This excluded the possibility ofthe activity
as anti-isotype antibodies and confirmed their anti-idiotype nature
(against the hypervariable part ofboth light and heavy chain ofthe
paraprotein). The anti-idiotype specificity of these antibodies was
further assessed by immunostaining of cytosmears and cryostat
sections, and by FACS analysis. Figure 1 clearly demonstrates the
shift in fluorescence ofsurface staining ofpart ofthe bone marrow
samples containing 5T2 MM (Figure IA) and 5T33 MM (Figure
1B), when stained with their corresponding anti-idiotype MAbs.
As a control, the same samples were stained in a first step with the
irrelevant antibody B 1 (anti-idiotype MAb B1 directed against
BCLI lymphoma) (Brissinck et al, 1991) ofthe same isotype (IgG,)
as the anti-idiotype antibodies. When the anti-idiotype antibodies
were used as first step in immunohistostainings on tumoral material,
an exclusive staining was observed (Figure 3), whereas controls
were negative. In all cases, no staining with the anti-idiotype anti-
bodies was observed when normal tissues or cell suspensions were
used. The staining was specific because no reaction was observed
on the MM-containing tumoral samples, when an irrelevant anti-
body of the same isotype (B1) was used in the first step instead of
the anti-idiotype.
Flow cytometry
Cells were washed and resuspended at 5 x 106 cells per sample in
PBS containing 2% BSA and 0.02% sodium azide. Anti-idiotype
antibodies were added at a concentration of 3 mg ml-' and incu-
bated for 30 min on ice. After washing, the cells were incubated
with rat anti-mouse-y, phycoerythrin-labelled antibodies (Becton
Dickinson, San Jose, CA, USA) for another 30 min on ice. Cells
were washed and fixed with 2% paraformaldehyde in PBS and
analysed (FACStar, Becton Dickinson, Mountain View, CA, USA).
Histology
In the first part of the experiment, two groups of 30 syngeneic
male mice were injected with cells ofeach ofthe two lines. In each
group five age-matched untreated mice, kept under the same
housing conditions, were used as controls. The mice inoculated
with 5T2 and 5T33 MM cells were sacrificed 13 weeks and 4
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Figure 5 Electron micrograph (bar = 1 gM) of (A) 5T2 MM and (B) 5T33 MM
cell
weeks after inoculation, respectively, at a time when an elevated
serum paraprotein could be detected consistently by ELISA or by
agarelectrophoresis. Blood smears were prepared and stained with
May-Grunwald-Giemsa. In the second part, kinetic experiments
were performed. Here, 36 and 21 mice were transplanted
simultaneously with 5T2 and 5T33 MM cells respectively. At 1, 2,
4, 6, 9, 10, 13, 15, 18, 20 and 21 weeks for 5T2 MM and 0.5, 1, 2,
3, 4 and 5 weeks for 5T33 MM cells after inoculation, three mice
were sacrificed at each point in time. For each series three mice
were followed up weekly during the course ofthe kinetic study. In
each case, serum paraprotein concentration was determined and
radiography was performed to assess the development of oste-
olytic lesions.
After killing, mice were dissected and liver and spleen were
weighed. Samples for fixation and freezing were taken from limbs,
vertebrae, ribs, liver, spleen, lymph nodes at the hilus of the lung,
periaortic lymph nodes, thymus, gastrointestinal tract, kidneys,
heart, lungs and testes. Part of the tissue blocks was frozen by
immersion in liquid nitrogen and another part was used for fixation
in 4% formalin before embedding in paraffin. Thebone-containing
samples were decalcified in EDTA (De-Cal Rapid, National
Diagnostics, Manville, NJ, USA) before fixation. Some bones were
flushed with RPMI-1640 medium to harvest bone marrow cells.
Sections from the embedded tissue blocks were stained with
haematoxylin-eosin or with Giemsa. A reticulin (Gomori) staining
was done on the bone marrow samples of ten mice in order to
examine the appearance offibrosis. Frozen sections were used for
immunohistochemical staining with anti-idiotype antibodies. All
sections were examined by light microscopy (Laborlux, Leica,
Germany).
Immunogold silver staining on cytospins
Mononuclear cells were prepared from bone marrow from mice 13
and 4 weeks after inoculation, for5T2 and 5T33 MM respectively.
Because of the strong paraprotein secretion, multiple washing
steps with PBS supplemented with 5% BSA at 4°C were
performed to avoid background staining. Cytospins of the cell
suspensions (at a concentration of 0.4 x 106 cells ml-l) were
prepared at 72 g during a 7-min spin (Cytospin-2, Shandon
Scientific, London, UK). Cytospins were stored at -20°C. After
thawing, cytosmears were fixed for 30 s at room temperature in a
buffered formol/acetone solution, followed by a preincubation
with 5% non-fat dry milk in PBS for 10 min. The first antibody,
either the anti-5T2 or anti-5T33 (3 ,ug ml-'), was incubated for 30
min followed by a second preincubation with 5% decomplemented
AB serum for 10 min. Afterrinsing, colloidal gold-labelled (5 nm)
goat anti-mouse IgG, antibodies (Auroprobe LM, Amersham
International, UK), at a dilution of 1:75, were incubated for 30 min
followed by extensive rinsing in distilled water. Silver enhance-
ment was subsequently performed with the Intense B1 Silver
Enhancement kit (British Biocell International, Sanvertech,
Cardiff, UK) for 15 min at 26'C (Iqbal et al, 1993). Cytospins
were counterstained with May-Grunwald-Giemsa.
As to the assessment of phenotypic adhesion profile, anti-LFA
lIx chain (clone M1714), anti-Mac-l a-chain (clone M1/70), anti-
VLA-4 a-chain (clone R1-2), anti-VLA-5 a-chain (clone 5H10-
27), anti-VLA 3-chain (clone 9EG7) and anti-CD44 (clone 1M7)
(all antibodies from Pharmingen, San Diego, CA, USA) were
used at a dilution of 1:100 as primary antibody and gold-labelled
goat anti-rat Ab (Auroprobe LM) were used as second step. As
negative control, irrelevant antibodies of the same isotype were
used as first step.
Immunohistochemistry and PCNA staining
Frozen tissue sections from all organs were labelled with the 5T2
or the 5T33 specific anti-idiotype antibodies. For the visualization
ofthe labelling we used the Histomouse kit (Zymed, Sanbio, Uden,
The Netherlands). Briefly, two blocking steps were followed by
overnight incubation at 4°C with the biotinylated anti-5T2 or5T33
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Figure 6 Kinetic series of (A) 5T2 MM and (B) 5T33 MM. Three mice were
evaluated at each point in time. The evolution of the serum paraprotein
concentration (mean of three mice, standard deviation was less than 20% of
the mean) was for both lines correlated with the occurrence of the MM cells
in the tissues and for the 5T2 MM also with the development of osteolysis.
Osteolysis was not consistently observed in the 5T33 MM-bearing mice. The
tissue involvement was assessed by both morphology and
immunohistochemistry. (BM, bone marrow; S, spleen; L, liver; LN, lymph
nodes)
antibody (1 ,ug ml-'), followed by rinsing and incubation with the
streptavidin-peroxidase complex for 30 min at room temperature.
Subsequently, a DAB reaction was performed followed by coun-
terstaining with haematoxylin. Because of the strong paraprotein
secretion, multiple washings between each step were needed to
avoid background staining. As negative control, corresponding
frozen tissue, obtained from tumour-free C57BL/KaLwRij mice,
was used in addition to irrelevant antibodies of the same isotype
(anti-idiotype MAb B1) on tumoral material.
For PCNA staining, cytosmears of isolated 5T2 and 5T33 MM
samples were fixed for 10 min in 4% formol in PBS. After rinsing
in PBS, endogenous peroxidase was blocked with 0.3% hydrogen
peroxide in methanol, again followed by rinsing in distilled water
and PBS. Normal goat serum (10% in 0.8% BSA in PBS) was
added on the sections for 10 min followed by an overnight
incubation with MAb to NCL-PCNA (clone PC1O) (Novocastra
Laboratories, Newcastle upon Tyne, UK) at a dilution of 1:50 in
PBS at 4°C, while irrelevant antibodies of the same isotype were
Table 1 Phenotypic adhesion profile as assessed by immunogold silver
staining on cytosmears
5T2 MM 5T33 MM
CD11a (a-chain LFA-1) 99.1 ± 0.7 99.8± 0.2
CD11b (a-chain Mac 1) 2.4± 2.5 1.2 ± 0.3
CD29 (5-chain VLA) 99.7 ± 0.3 99.6 ± 0.0
CD44 (H-CAM) 99.1 ± 0.2 99.7 ± 0.3
CD49d (a-chain VLA-4) 99.5 ± 0.5 99.6 ± 0.4
CD49e (a-chain VLA-5) 99.6 ± 0.1 99.9 ± 0.1
Five hundred MM cells were counted on each slide. Three independent
experiments were performed. Data are presented as the means ± standard
deviation. LFA-1, lymphocyte function antigen-1; VLA, very late activation
antigen; H-CAM, homing-associated cell adhesion molecule
used as controls. After extensive rinsing with PBS, anti-mouse
IgG2a-specific antibodies coupled to horseradish peroxidase
(Southern Biotechnology Associates, Birmingham, UK) were
added at a dilution of 1:100 for 30 min. After rinsing with PBS,
peroxidase was visualized by a DAB reaction, followed by a brief
counterstaining with May-Grunwald-Giemsa. For each 5T2 and
5T33 MM, 500 MM cells were counted in three independent exper-
iments. Results are presented as the mean with standard deviation.
Cell preparation for electron microscopy
Cells were spun to a pellet with a Beckman Microfuge (Analys,
Namen, Belgium) in Eppendorf tubes in a solution of 2.5%
glutaraldehyde. This was followed by 1-h incubation with 0.1%
osmium tetroxide. Pellets were subsequently dehydrated in agraded
ethanol series, infiltrated withpropylene-oxide-Epon and embedded
in Epon. Ultrathin sections were stained with uranyl acetate and lead
citrate. They were subsequently examined by transmission electron
microscopy (Zeiss TEM 109, Oberkochen, Gennany).
Radiography
Bone lesions were evaluated in mice by radiography dedicated for
mammography. Briefly, mice were anaesthetized and a radiograph
ofpelvis and hind legs was performed (Vanderkerken et al, 1996).
This method allowed the follow-up of bone lesions in the same
mouse.
RESULTS
Histology
Thirty 5T2 MM and 30 5T33 MM inoculated mice and ten control
mice were investigated for organ infiltration with MM cells 13 and
4 weeks after transplantation respectively.
For the 5T2 MM cells (Figures 2-4) all mice had bone marrow
infiltration 13 weeks after inoculation whereas the spleen was
invaded in only 46% of mice (Figure 4) with a focal infiltration
and a 1.5-fold increase in weight. An infiltration of the liver was
observed in only 7% of mice, whereas lymph nodes were invaded
minimally in 25% of mice. No tumoral cells were observed in the
peripheral blood.
The infiltration of the 5T2 MM cells in the bone marrow was
uneven. At sites of bone involvement, myeloma cells showed a
diffuse growth pattern. Although most myeloma cells had a plas-
mablastic morphology with extensive rough endoplasmic reticulum
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Figure 7 Radiograph of the femur of a 5T2 MM-positive animal showing
numerous osteolytic lesions (arrows)
(Figure 5), some features of plasma cell differentiation, such as a
slightly eccentrically located nucleus and a cartwheel chromatin
pattem, could also be observed. With the Gomori stain no increase
in reticulin fibres was observed. At sites ofinvolvement, a decrease
in the number of bone trabeculae could consistently be observed.
The cortical bone was thinned compared with the control mice. The
liver infiltration consisted of a small solitary aggregate composed
ofa few MM cells. An increase in liver weight was neverobserved.
The lymph node infiltration was mainly localized in the sinuses and
the interfollicular areas and was never accompanied by a peri-
ganglionic spread.
The organ distribution of myeloma cells was confirmed with
immunohistochemical labelling on frozen sections using the MM
anti-idiotype antibodies (Figure 3). The MM cells showed a cyto-
plasmic positivity with variable intensity. No positive cells could
be observed in the tissues from the control mice.
All 5T33 MM-inoculated mice showed a bone marrow infiltra-
tion. The liver and spleen were involved in 82% and 96% of the
mice respectively. This tissue infiltration was associated with a
hepatomegaly (threefold increase in weight) and a splenomegaly
(20- to 30-fold increase). At least one lymph node was infiltrated
in 58% oftested mice (Figures 2-4). Heart, blood, lung, intestine,
kidneys, thymus and testes remained tumour free. Histological
study of all infiltrated organs has been performed. The myeloma
cell population in the bone marrow was unevenly distributed. At
sites of bone marrow involvement, the myeloma cell growth was
diffuse. At sites of bone destruction, a local spread into the
surrounding soft tissue could be observed. The MM cells had a
blastic morphology with a vesicular nucleus and several distinct
nucleoli and extensive rough endoplasmic reticulum (Figure 5).
The cytoplasm was basophilic on the Giemsa staining. There was a
marked polymorphism. Mitotic figures could easily be found.
There was no increase in reticulin fibres on the Gomori stain ofthe
bone marrow samples. A destruction of cortical bone and a
decrease in bone trabeculae was observed at sites of invasion. In
the liver the myeloma cells were located along the sinuses and the
portal tracts. In the spleen all 5T33 MM cells were observed in the
red pulp. Massively infiltrated lymph nodes showed a pen-
ganglionic spread.
PCNA staining illustrated the higher proliferative index of the
5T33 MM cells, when compared with the 5T2 MM cells:
55.6 ± 9.0 and 5.3 ± 1.1 ofthe MM cells (mean ± standard devia-
tion) were positive, for 5T33 and 5T2 MM cells respectively.
Kinetics
In the kinetic series ofthe 5T2 MM (Figure 6A), isolated idiotype-
positive cells were observed by immunohistochemistry from week
9 in some bone marrow and spleen samples. From week 10, all
bone marrow samples and half of the spleen samples contained
idiotype-positive cells, which was also confirmed by morphology.
Lymph nodes were infiltrated from week 13. Significant parapro-
tein was detected in the serum by proteinelectrophoresis from
week 9 and the concentration augmented during the course of the
disease. Positivity in ELISA could be detected from week 4.
Minimal osteolytic lesions could be observed from week 10, all
evolving to numerous small cavities (Figure 7) and eventually
resulting in bone fractures at the terminal stage of the disease
(from week 20). At this last stage, no other organs than bone
marrow, spleen and liver were histologically involved by the 5T2
MM cells.
For5T33 MM (Figure 6B), both immunohistochemistry with the
anti-5T33 MM idiotype MAb and the morphology on paraffin
sections revealed the involvement ofbone marrow, liverand spleen
from week 2. At the same time, paraprotein could be detected in
the serum by protein electrophoresis. ELISA could demonstrate
paraprotein in the serum from week 1. In the terminal stage of the
disease (from week 6), paralysis ofthe hind legs is often observed.
As in the 5T2 MM, no other organs were involved atthis stage than
those mentioned above. Osteolysis could be observed in some
animals from week4, but was not consistent for all.
Phenotypic adhesion profile
Table 1 illustrates the phenotypic adhesion profile as assessed by
immunogold silver staining on cytosmears. Both 5T2 and 5T33
MM cells isolated from the bone marrow were LFA-1 a-chain
(CDlla) positive, Mac-I a-chain (CDlib) negative, VLA-4
(CD49d-CD29) positive, VLA-5 (CD49e-CD29) positive. The
5T2 and 5T33 MM cells were recognized on the basis of their
typical blastic morphology.
DISCUSSION
The general purpose of this work was to study the homing and
organ distribution and the phenotypic adhesion profile of experi-
mental mouse multiple myeloma lines. The 5T2 and 5T33 MM
lines that spontaneously occurred in C57BL/KaLwRij mice (Radl
et al, 1979) and have since been propagated in vivo by intravenous
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transfer into young syngeneic recipients. Both lines share similar
general properties with human MM: spontaneous origin, the
development of the disease can be monitored by the serum para-
protein concentration and osteolysis occurs.
Homing of lymphocytes is generally defined as the selective
recruitment of specific lymphocyte subsets, under strict microen-
vironmental control (Picker et al, 1994). The local microenviron-
mentdifferentially regulates the adhesion molecule expression and
thus controls the adhesion of specific lymphocyte subsets to cells
or extracellular matrix proteins within a tissue. A multistep model
of this homing has been proposed (Picker et al, 1994): an initial
unstable adhesion to endothelial cells is then followed by an
activation-dependent stable secondary adhesion. This can subse-
quently be followed by transendothelial migration into the tissues.
Here, chemoattractants will regulate the migration and tertiary
adhesion to tissue components such as fixed cells or extracellular
matrix components. The potential requirements of the different
sequential regulated steps generates a specificity that exceeds that
ofits component steps (Butcher and Picker, 1996).
To influence this homing and growth ofMM cells through adhe-
sion molecules involved in the secondary and tertiary adhesion,
the phenotypic adhesion profile of the MM cells and a detailed
study of all organs involved by these tumoral 5TMM cells is
necessary. Thus, mice injected intravenously with myeloma cells
were submitted to a serial killing experiment. When a clear-cut
serum paraprotein concentration was observed in all mice, the
organ distribution of the two 5T MM lines was analysed by a
combination of histology and immunohistochemistry. For the
latter, specific monoclonal anti-idiotype antibodies were devel-
oped for each line. FACS analysis, immunostainings on
cytosmears and cryostat sections as well as ELISA demonstrated
the specificity ofthese antibodies. All mice analysed for each line
exhibited a homologous tissue pattern.
Thegrowth ofthe 5T2 MM cells was more restricted to the bone
marrow and the disease showed a less progressive evolution.
Nearly halfofthe mice showed a limited infiltration ofthe spleen,
whereas only a very low percentage ofmice showed an infiltration
in the liver. In contrast, Radl et al (1988) did not find a liver infil-
tration in the 5T2 MM-bearing mice.
The 'take' of the 5T33 MM cells was fast, and by the fourth
week a massive infiltration of bone marrow, spleen and liver
resulted inparalysis ofhind legs, splenomegaly and hepatomegaly.
Lymph nodes were infiltrated in most of the mice. A perigan-
glionic spread and spread into the surrounding soft tissue at sites
ofbone destruction was frequently observed.
The fact that the spleen is involved in both MM lines is not
surprising as in mice, in contrast to humans, the spleen retains its
haematopoietic function after birth. The infiltration of 5T33 and,
occasionally, 5T2 MM in the liver can also be explained by the fact
that the liver is the major site ofhaemopoiesis not only during fetal
life, but also in adults and the liver still retains an environment that
can support haemopoiesis (Taniguchi et al, 1996). In some cases,
when the function of the bone marrow is severely suppressed, as
afteraccidental radiation exposure, an extramedullary haemopoiesis
occurs in the liver.
We did not observe an infiltration in the thymus, in either 5T2 or
5T33 MM (by both morphology and immunohistochemistry with
the anti-idiotype antibodies); this is in contrast to the data of
Manning et al (1992), who could identify a small subpopulation of
cytoplasmic 1g2b cells in the thymus of5T33 MM-inoculated mice
by indirect immunofluorescence.
When comparing the organ involvement of the two 5TMM
lines, we should stress that the 5T2 MM cells are mainly located in
the bone marrow and only a minor infiltration is observed in red
pulp of the spleen and liver, whereas in the 5T33 MM the bone
marrow infiltration is accompanied by a massive infiltration of
liver and spleen in nearly all mice.
The higher proliferation index of the 5T33 MM cells, as illus-
trated by PCNA staining, confirmed their more aggressive growth
when compared with the 5T2 MM cells. PCNA/cyclin is a highly
conserved (between species) acidic nuclear protein that is synthe-
sized in late G1 and S phase and is present throughout the cell
cycle except in theG0 state. PCNA expression is therefore corre-
lated with the cell cycle. Several authors have suggested this
staining as an alternative for thymidine pulse labelling, especially
in pre-existing fixed or frozen materials (Galand et al, 1989;
Kawakita et al, 1992). We are aware that PCNA staining gives an
overestimation of proliferation when compared with 'classical'
thymidine incorporation because all cells, except those in Go state,
are stained. However, the clear difference in staining between the
two cell lines, 5T2 and 5T33 MM, confirms the more proliferative
behaviour of the 5T33 MM line, which is in agreement with the
observations of numerous mitotic figures and with their rapid
'take' time (even after injection of 20 times fewer cells).
The kinetic experiments performed forboth lines clearly demon-
strate a correlation between the occurrence ofMM cells, the serum
paraprotein content and, for the 5T2 MM, the development of
osteolytic lesions. For both lines, all organs, i.e. bone marrow and
spleen for 5T2 MM and bone marrow, spleen and liver for 5T33
MM, were infiltrated simultaneously and at the terminal stage of
the disease no 'overflow' to other organs was observed, indicating
their homing restriction to haematopoietic environments.
A striking feature of human MM is that the malignant plasma
cells home to and proliferate in the bone marrow. Only in advanced
stages of the disease are circulating MM cells observed in the
peripheral blood. The interactions between MM cells and stromal
cells and extracellular matrix proteins are mediated by cellular
adhesion molecules. These molecules can be divided into four
families: the Ig superfamily, the integrins, the selectins and the
cadherins. Studies on human MM implied mainly the integrin
family and CD44 (H-CAM). Integrins are known to be important in
the dynamic regulation of adhesion and migration of lymphocytes.
They consist of Ab heterodimers. ,B1 and P3 integrins mediate
cell-matrix interactions, whereas the ,B2 integrin is responsible for
cell-cell contact. ,B1 integrin was extensively studied in human
MM. All MMs appeared to be a4,l (VLA-4) positive (Van Riet
and Van Camp, 1993; Pellat-Deceunynk et al, 1995b; Kawano,
1993). It was demonstrated that VLA-4-fibronectin interaction is
necessary for the terminal differentiation of lg-secreting bone
marrow cells (Roldan et al, 1992). The ca5[1 (VLA-5) integrin is
expressed on subpopulations of freshly isolated MM cells (Pellat-
Deceunynk et al, 1995b; Kawano et al, 1993). Furthermore, the
expression of VLA-5 is associated with more mature subpopula-
tions. The expression of C.L integrin, LFA-1 (CDlla), is more
controversial. Some authors have demonstrated that MM cells are
LFA-1 negative (Van Riet and Van Camp, 1993), whereas others
observed a correlation with LFA-1 expression in patients with
fulminant disease (Ashmann et al, 1992). Furthermore, a correla-
tion between VLA-5 and CDlla expression was observed in some
patients (Kawano et al, 1993; Pellat-Deceunynk et al, 1995b). LFA-
l-ICAM-1 interactions have been found to be responsible for
homotypic cell aggregations of human MM in culture (Kawano et
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al, 1991). Several authors have reported the absence ofthe CD11b
marker on all myeloma cells studied (Uchiyama et al, 1992; Van
Riet and Van Camp, 1993; Kim et al, 1994; Pellat-Deceunynk et al,
1995a). Mac-I (CD1lb-CD18) is mainly expressed on monocytes
and granulocytes and is involved in the adhesion of these cells to
endothelial cells and their localization at sites ofinflammation.
CD44 has been linked to site-specific extravasation of lympho-
cytes into tissues, to site-directed homing ofB and T lymphocytes
and to binding to extracellular matrix proteins. Degrassi (1993)
demonstrated that the interaction of CD44 with its ligand
hyaluronate was responsible for part of the adhesion of plasma-
cytomas on stromal cell layers.
Ourfindings ofphenotypic adhesion profile in the 5T2 MM, i.e.
LFA-1, VLA-4, VLA-5, CD44 positivity and Mac-I negativity,
thus corresponds to the data obtained on freshly isolated human
MM cells.
The 5T33 MM model may be representative of an aggressive
human variant of MM (Bartl R et al, 1991) that is clinically char-
acterized by a rapidly aggressive course with a mean survival of
less than 6 months and a high incidence of hepatosplenomegaly
and complications. This variant ishistologically characterized by a
packed marrow, a blastic cell type and a high mitotic rate.
In contrast, the 5T2 MM model more closely resembles the clas-
sical presentation of human MM in several aspects: the course of
the disease is moderately progressive, the homing is more
restricted to thebone marrow, some maturation towards the plasma
cell can be observed and the development ofosteolysis can consis-
tently be observed during the course of the disease (Radl, 1985;
Vanderkerken et al, 1996). Further, the in vitro growth is 'stroma
dependent'. Preliminary experiments could demonstrate some
growth of 5T2 MM in vitro when co-cultured with a stromal cell
layer (consisting of bone marrow fibroblasts) (unpublished data).
In contrast, 5T33 MM cells grow in a stroma-independent fashion
(Degrassi et al, 1993).
Most artificial animal models use human MM cell lines injected
into severe combined immunodeficient (SCID) mice (Huang et al,
1993; Alsina et al, 1995), chemically induced mouse plasmacy-
tomas (Degrassi et al, 1993) or genetically modified hybridomas
(Okada et al, 1995). As in human MM, it is expected that the inter-
actions of mouse MM cells with the stromal cells and osteoclasts
are based on a complex network of cytokines and adhesion
molecules, inducing a paracrine proliferation of MM. The above-
mentioned experimental models might lack these interactions. In
addition, a recent report (Pellat-Deceunynk et al, 1995a) stresses
the importance of choice of human MM lines in the study in
SCID mice. It appears that lymphoblastoid cell lines (LCL) are
frequently being used. These lines are formed by immortalization
ofnon-malignant B cells by Epstein-Barr virus (EBV) and present
karyotypes completely differentfrom those ofgenuine human MM
lines which are EBV negative and which have chromosomal
abnormalities identical to those offresh tumour cells.
We conclude that the 5T2 MM very closely resembles the
human disease and therefore is more suitable for the study of the
biology ofMM than most artificial models. Future work will focus
on the mechanism ofselective homing ofthe MM cells to the bone
marrow. Studies on human co-cultures of MM cells with fibro-
blasts (Uchiyama et al, 1993; Lokhorst et al, 1994; Faid, 1996)
have already demonstrated that interactions other than with the
known adhesion molecules areinvolved in the adhesion andprolif-
eration of MM cells. We will therefore also consider mechanisms
like those involving cytoskeletal and/or motility changes.
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